About AlveoliX
AlveoliX is a company based in Bern (Switzerland) founded in 2015. AlveoliX offers products and services including AX Barrier-on-Chip System, AX Lung-on-Chip System, and AX Biomodels. AlveoliX operates in a competitive market with competitors including ACXEL, Axbio, SpacePharma, Micronit and NanoEntek, among others.
- Headquarter Bern, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Alveolix Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AlveoliX
AlveoliX offers a comprehensive portfolio of products and services, including AX Barrier-on-Chip System, AX Lung-on-Chip System, and AX Biomodels.
Simulates organ barriers for drug testing and research applications.
Mimics lung environments to study respiratory drug effects.
Provides models inspired by nature for complex human body emulation.
People of AlveoliX
Unlock access to complete
Biologist Team
1 people
Leadership Team
1 people
Operations Team
1 people
CTO Team
1 people
Unlock access to complete
Funding Insights of AlveoliX
Investors in AlveoliX
AlveoliX has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Eureka Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Business management consulting services are offered to clients.
|
Locked | Locked | Locked |
Investor details for AlveoliX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AlveoliX
Investment portfolio details for AlveoliX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AlveoliX
Detailed financials for AlveoliX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alveolix Comparisons
Peer comparison for AlveoliX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AlveoliX
AlveoliX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ACXEL, Axbio, SpacePharma, Micronit and NanoEntek, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microfluidic technology and solutions are provided for life sciences industries.
|
|
| Locked | Locked | Locked |
Developer of a lab on chip microfluidic platform for sequencing and molecular diagnostics using AI
|
|
| Locked | Locked | Locked |
Microgravity research solutions are provided for researchers and companies.
|
|
| Locked | Locked | Locked |
Microfluidic devices and lab-on-chip solutions are designed and manufactured.
|
|
| Locked | Locked | Locked |
Point-of-care instruments for diagnostics and research are developed.
|
|
| Locked | Locked | Locked |
Microfluidics and microtechnology solutions are developed for drug permeability testing.
|
Detailed competitors of AlveoliX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alveolix
Complete news archive for AlveoliX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AlveoliX
AlveoliX was founded in 2015 and raised its 1st funding round 4 years after it was founded.
AlveoliX is headquartered in Bern, Switzerland. It is registered at Bern, Bern, Switzerland.
Developer of organ-on-chip technologies to enable more efficient drug development. The lead product Lung-on-Chip system is an in-vitro model that closely mimics the biophysical characteristics of the lung, including the mechanical stress induced by respiration. This model is expected to best predict the effects of respiratory drug candidates in humans.
AlveoliX's top competitors include Noul, Suzhou Akso Biotechnology and Axbio.
AlveoliX offers AX Barrier-on-Chip System, AX Lung-on-Chip System, and AX Biomodels.
AlveoliX has 1 investor. Key investors include Eureka Network.